Telemedicine in the COVID-19 Era: Taking Care of Children with Obesity and Diabetes Mellitus

Overview

Journal World J Diabetes

Publisher Baishideng Publishing Group

Specialty Endocrinology

Date 2021 May 17

PMID 33995852

Citations 12

Authors

Giuseppina Rosaria Umano

Anna Di Sessa

Stefano Guarino

Giuseppina Gaudino

Pierluigi Marzuillo

Emanuele Miraglia Del Giudice

Affiliations

Soon will be listed here.

Abstract

Severe acute respiratory syndrome coronavirus 2 infection was declared a pandemic in January 2020. Since then, several measures to limit virus transmission have been imposed; among them, home confinement has been the most severe, with drastic changes in the daily routines of the general population. The "stay at home" rule has impaired healthcare service access, and patients with chronic conditions were the most exposed to the negative effects of this limitation. There is strong evidence of the worsening of obesity and diabetes mellitus in children during this period. To overcome these issues, healthcare providers have changed their clinical practice to ensure follow-up visits and medical consultation though the use of telemedicine. Telemedicine, including telephone calls, videocalls, data platforms of shared telemedicine data platforms mitigated the negative effect of pandemic restrictions. Published evidence has documented good metabolic control and weight management outcomes in centers that performed extensive telemedicine services last year during the pandemic. This review discusses studies that investigated the use of telemedicine tools for the management of pediatric obesity and diabetes.

Citing Articles

Telemedicine for Managing Type 1 Diabetes in Children and Adolescents Before and After the COVID-19 Pandemic.

Fogliazza F, Sambati V, Iovane B, Lazzeroni P, Street M, Esposito S J Clin Med. 2024; 13(23).

PMID: 39685817 PMC: 11642187. DOI: 10.3390/jcm13237359.

Challenges of using telemedicine for patients with diabetes during the COVID-19 pandemic: A scoping review.

Mirasghari F, Ayatollahi H, Velayati F, Abasi A J Clin Transl Endocrinol. 2024; 37:100361.

PMID: 39114582 PMC: 11304064. DOI: 10.1016/j.jcte.2024.100361.

Public and Research Interest in Telemedicine From 2017 to 2022: Infodemiology Study of Google Trends Data and Bibliometric Analysis of Scientific Literature.

Maugeri A, Barchitta M, Basile G, Agodi A J Med Internet Res. 2024; 26:e50088.

PMID: 38753427 PMC: 11140276. DOI: 10.2196/50088.

The Ongoing Impact of COVID-19 on Pediatric Obesity.

Iacopetta D, Catalano A, Ceramella J, Pellegrino M, Marra M, Scali E Pediatr Rep. 2024; 16(1):135-150.

PMID: 38391001 PMC: 10885050. DOI: 10.3390/pediatric16010013.

Multiple influences of the COVID-19 pandemic on children with diabetes: Changes in epidemiology, metabolic control and medical care.

Zucchini S, Scozzarella A, Maltoni G World J Diabetes. 2023; 14(3):198-208.

PMID: 37035223 PMC: 10075036. DOI: 10.4239/wjd.v14.i3.198.

References

Zhai Y, Zhu W, Cai Y, Sun D, Zhao J . Clinical- and cost-effectiveness of telemedicine in type 2 diabetes mellitus: a systematic review and meta-analysis. Medicine (Baltimore). 2014; 93(28):e312. PMC: 4603080. DOI: 10.1097/MD.0000000000000312. View

Wang S, Chen L, Hsu S, Wang S . Health care utilization and health outcomes: a population study of Taiwan. Health Policy Plan. 2012; 27(7):590-9. DOI: 10.1093/heapol/czr080. View

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

C Grossman D, Bibbins-Domingo K, Curry S, Barry M, Davidson K, Doubeni C . Screening for Obesity in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. JAMA. 2017; 317(23):2417-2426. DOI: 10.1001/jama.2017.6803. View

Turner T, Spruijt-Metz D, Wen C, Hingle M . Prevention and treatment of pediatric obesity using mobile and wireless technologies: a systematic review. Pediatr Obes. 2015; 10(6):403-9. PMC: 4499498. DOI: 10.1111/ijpo.12002. View

Tornese G, Ceconi V, Monasta L, Carletti C, Faleschini E, Barbi E . Glycemic Control in Type 1 Diabetes Mellitus During COVID-19 Quarantine and the Role of In-Home Physical Activity. Diabetes Technol Ther. 2020; 22(6):462-467. DOI: 10.1089/dia.2020.0169. View

Galiero R, Pafundi P, Nevola R, Rinaldi L, Acierno C, Caturano A . The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy. J Diabetes Res. 2020; 2020:9036847. PMC: 7584941. DOI: 10.1155/2020/9036847. View

Flodgren G, Rachas A, Farmer A, Inzitari M, Shepperd S . Interactive telemedicine: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2015; (9):CD002098. PMC: 6473731. DOI: 10.1002/14651858.CD002098.pub2. View

Rabbone I, Schiaffini R, Cherubini V, Maffeis C, Scaramuzza A . Has COVID-19 Delayed the Diagnosis and Worsened the Presentation of Type 1 Diabetes in Children?. Diabetes Care. 2020; 43(11):2870-2872. DOI: 10.2337/dc20-1321. View

10.

Banerjee M, Chakraborty S, Pal R . Diabetes self-management amid COVID-19 pandemic. Diabetes Metab Syndr. 2020; 14(4):351-354. PMC: 7194953. DOI: 10.1016/j.dsx.2020.04.013. View

11.

Nagata J, Abdel Magid H, Pettee Gabriel K . Screen Time for Children and Adolescents During the Coronavirus Disease 2019 Pandemic. Obesity (Silver Spring). 2020; 28(9):1582-1583. PMC: 7283714. DOI: 10.1002/oby.22917. View

12.

Iughetti L, Trevisani V, Cattini U, Bruzzi P, Lucaccioni L, Madeo S . COVID-19 and Type 1 Diabetes: Concerns and Challenges. Acta Biomed. 2020; 91(3):e2020033. PMC: 7716973. DOI: 10.23750/abm.v91i3.10366. View

13.

DAnnunzio G, Maffeis C, Cherubini V, Rabbone I, Scaramuzza A, Schiaffini R . Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia. Diabetes Res Clin Pract. 2020; 168:108372. PMC: 7438223. DOI: 10.1016/j.diabres.2020.108372. View

14.

Cuschieri S, Grech S . COVID-19: a one-way ticket to a global childhood obesity crisis?. J Diabetes Metab Disord. 2020; 19(2):2027-2030. PMC: 7644278. DOI: 10.1007/s40200-020-00682-2. View

15.

Elbarbary N, Dos Santos T, de Beaufort C, Agwu J, Calliari L, Scaramuzza A . COVID-19 outbreak and pediatric diabetes: Perceptions of health care professionals worldwide. Pediatr Diabetes. 2020; 21(7):1083-1092. PMC: 7404589. DOI: 10.1111/pedi.13084. View

16.

Ludvigsson J . Effect of COVID-19 pandemic on treatment of Type 1 diabetes in children. Acta Paediatr. 2020; 110(3):933-934. PMC: 7984368. DOI: 10.1111/apa.15627. View

17.

Woo Baidal J, Chang J, Hulse E, Turetsky R, Parkinson K, Rausch J . Zooming Toward a Telehealth Solution for Vulnerable Children with Obesity During Coronavirus Disease 2019. Obesity (Silver Spring). 2020; 28(7):1184-1186. PMC: 7267304. DOI: 10.1002/oby.22860. View

18.

Predieri B, Leo F, Candia F, Lucaccioni L, Madeo S, Pugliese M . Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic. Front Endocrinol (Lausanne). 2021; 11:595735. PMC: 7793913. DOI: 10.3389/fendo.2020.595735. View

19.

Cristello Sarteau A, Souris K, Wang J, Ramadan A, Addala A, Bowlby D . Changes to care delivery at nine international pediatric diabetes clinics in response to the COVID-19 global pandemic. Pediatr Diabetes. 2021; 22(3):463-468. PMC: 8013674. DOI: 10.1111/pedi.13180. View

20.

Pietrobelli A, Pecoraro L, Ferruzzi A, Heo M, Faith M, Zoller T . Effects of COVID-19 Lockdown on Lifestyle Behaviors in Children with Obesity Living in Verona, Italy: A Longitudinal Study. Obesity (Silver Spring). 2020; 28(8):1382-1385. PMC: 7267384. DOI: 10.1002/oby.22861. View